ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency

ClinicalTrials.gov ID: NCT01289847

Public ClinicalTrials.gov record NCT01289847. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents

Study identification

NCT ID
NCT01289847
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bio Products Laboratory
Other
Enrollment
25 participants

Conditions and interventions

Eligibility (public fields only)

Age range
2 Years to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2011
Primary completion
Mar 31, 2014
Completion
Mar 31, 2014
Last update posted
Dec 22, 2014

2011 – 2014

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Department of Medicine, University of California Irvine California 92697.
Children's Hospital Los Angeles Los Angeles California 90027
IMMUNOe International Reseach Centers Centennial Colorado 80112
Family Allergy & Asthma Center, PC Atlanta Georgia 30342
Rush University Medical Center Chicago Illinois 60612
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224
Allergy, Asthma & Immunology Clinic, P.A Irving Texas 75063
Children's Hospital of Richmond, VA Richmond Virginia 23219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01289847, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2014 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01289847 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →